3GENES

We’re excited to introduce a new long-read sequencing chemistry for Revio in response to the tremendous demand for the Revio long-read sequencing systems over the last two years as many more researchers have discovered the superiority of HiFi technology. Learn more about all the enhancements offered by the new SPRQ chemistry, including reduced DNA input by 4x, improved accuracy for methylation calling, and expanded support for multiomics. https://bit.ly/4for8D2 #PacBio #Revio #ASHG24

What an exceptional gathering of genomics experts at OncoDNA's European User Group meeting! Our event fostered meaningful exchanges on experiences, challenges, and best practices in integrating 𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗚𝗲𝗻𝗼𝗺𝗶𝗰 𝗣𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴 (𝗖𝗚𝗣) into routine clinical laboratory workflows. A heartfelt thank you to all participants for their valuable insights and thought-provoking discussions! Looking forward to the next edition! Can't join us? No problem! Comment on this post, and we'd be happy to share key takeaways with you. 👇

Discover the Future of Biomarker Detection with QF-Pro® 🔬 We are excited to share our latest webinar featuring Prof. Peter Parker and James Miles, Product Manager at HAWK Biosystems. Dive deep into the cutting-edge QF-Pro® Functional Biomarkers platform and see how Violet 3.0, our microscopy technology, is reshaping the future of biomarker detection by revealing interactions within 10 nm in cells and tissues. This breakthrough technology is transforming how we approach biomarker research, from drug development to patient-specific treatment insights. 🎥 Watch the full webinar here: https://lnkd.in/dBgNddwu

We are thrilled to see the 2024 Nobel Prize in Physiology or Medicine awarded to the groundbreaking discoveries in miRNA- small but mighty molecules that play crucial roles in regulating gene expression! RealSeq is excited to continue leveraging our expertise in miRNA detection to enable the development of highly sensitive diagnostics across a range of diseases, including fungal infections like Valley Fever.

In our recent LinkedIn poll, the rise of CRISPR-Cas9 technology stood out to you as the most memorable innovation of the 2010s. Now, join us as we revisit this exciting era in genomics with an interview with PacBio Founder, Stephen Turner, PhD. Hear his thoughts on the breakthroughs that shaped genomics and discover where he thinks the field is headed next. #PacBio #WelcomeToTomorrow

Who says magic isn’t real? In Franklin, it’s all about the hidden features. Unlock the secrets to a more powerful experience! Today’s mysterious spell is 🥁 Manually Add/Edit Variants – take full control by manually adjusting your variants for a tailored analysis. To learn more about mastering your data with precision, click the link below. Believe in your own magic? We do too! Help Us Shape the Future of Franklin! We know that real magic happens when our community shares its wisdom. Use the link in the comments to suggest the features you’d love to see in Franklin. Your ideas are the key ingredients to our magical brew! #GeneChat #Genomics #DataMastery https://lnkd.in/exD3Jpze

Performing PacBio long-read sequencing? The LongPlex Long Fragment Multiplexing Kit is here to help you make short work of long-reads. Get the most out of your PacBio Revio or Sequel IIe system by realizing its full throughput potential without sacrificing data quality. No more time-consuming DNA shearing! LongPlex is a plate-based transposase-based method to simultaneously fragment and index genomic DNA creating a rapid, automation-friendly workflow that enables sample pooling for multiplexing upstream of the PacBio SMRTbell prep kit 3.0. Hear directly from early access customers at our virtual LongPlex Launch Celebration on October 8th. https://hubs.ly/Q02R3Bxq0 #longread

Lili Milani and I sat down with Jim Cornall on Labiotech.eu Beyond Biotech podcast to discuss the collaboration between PacBio and the Estonian National Biobank. Estonia is working on becoming the first country to implement personalized health at scale through its National Biobank. Its new project is using PacBio sequencing technology to build a picture of the Estonian population and inform public health systems. 🔎 To learn more, listen to the full podcast episode, here. 👉https://bit.ly/3MSFqiX 🔗 #Genomics #PacBio

We are delighted to share below a recent GenomeWeb article relating how Hedera Dx is transforming cancer care by leveraging liquid biopsy and real-world data (RWD) to improve patient outcomes. With the launch of Hedera Frame, we are connecting high-quality genomics with deep clinical data to drive adoption of liquid biopsy technologies across hospital laboratories in Europe. Hedera Frame encompasses EMPATHY NSCLC, a prospective, international, multicenter, observational study that is already on its way by recruiting patients across multiple European sites. The study will provide crucial data on the real-world clinical utility of liquid biopsies in guiding treatment decisions. At Hedera Dx, we’re committed to advancing precision oncology, helping both patients and the oncology community by making real-world data insights accessible. Stay tuned for future expansions, including EMPATHY Prostate and EMPATHY Breast, as we continue to innovate for a healthier future! https://lnkd.in/dZwqx9GJ #CancerCare #LiquidBiopsy #RealWorldData #RealWorldEvidence #HealthcareInnovation #CancerResearch